{"id":"https://openalex.org/W4387981978","doi":"https://doi.org/10.1183/13993003.congress-2023.pa5205","title":"Identification of negative regulators of Wnt/\u03b2-catenin signaling in lung epithelial cells through whole genome CRISPR screen","display_name":"Identification of negative regulators of Wnt/\u03b2-catenin signaling in lung epithelial cells through whole genome CRISPR screen","publication_year":2023,"publication_date":"2023-09-09","ids":{"openalex":"https://openalex.org/W4387981978","doi":"https://doi.org/10.1183/13993003.congress-2023.pa5205"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2023.pa5205","doi":"https://doi.org/10.1183/13993003.congress-2023.pa5205","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2023.pa5205","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pathology and functional genomics","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041417253","display_name":"Markus Tammia","orcid":"https://orcid.org/0000-0001-6217-4813","observed_orcids":["https://orcid.org/0000-0001-6217-4813"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Markus Tammia","raw_affiliation_strings":["Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086180381","display_name":"Anna S. Dickson","orcid":"https://orcid.org/0000-0001-6431-586X","observed_orcids":["https://orcid.org/0000-0001-6431-586X"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anna Dickson","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003379657","display_name":"Niamh Mullooly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Niamh Mullooly","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039651767","display_name":"Adam\u00a0M. Corrigan","orcid":"https://orcid.org/0000-0001-5142-6579","observed_orcids":["https://orcid.org/0000-0001-5142-6579"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adam Corrigan","raw_affiliation_strings":["Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000500798","display_name":"Alessia Serrano","orcid":"https://orcid.org/0000-0002-7622-0101","observed_orcids":["https://orcid.org/0000-0002-7622-0101"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alessia Serrano","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079161681","display_name":"Yaxin Xue","orcid":"https://orcid.org/0000-0003-2395-4176","observed_orcids":["https://orcid.org/0000-0003-2395-4176"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Yaxin Xue","raw_affiliation_strings":["Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Chang Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Chang Kim","raw_affiliation_strings":["Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088654443","display_name":"Ewa Ko\u0142osionek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ewa Kolosionek","raw_affiliation_strings":["Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology (R&I), Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology (R&I), Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Stefan Vollmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Stefan Vollmer","raw_affiliation_strings":["Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology (R&I), Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience COPD/IPF, Research and Early Development, Respiratory and Immunology (R&I), Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030900604","display_name":"Bairu Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bairu Zhang","raw_affiliation_strings":["Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077735093","display_name":"Leire Escudero\u2010Ibarz","orcid":"https://orcid.org/0000-0001-7650-131X","observed_orcids":["https://orcid.org/0000-0001-7650-131X"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Leire Escudero-Ibarz","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019584403","display_name":"Valentina Quarantotti","orcid":"https://orcid.org/0000-0003-4544-9939","observed_orcids":["https://orcid.org/0000-0003-4544-9939"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Valentina Quarantotti","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052314402","display_name":"Gabriella Leung","orcid":"https://orcid.org/0000-0002-8754-1621","observed_orcids":["https://orcid.org/0000-0002-8754-1621"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Gabriella Leung","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062179210","display_name":"Daniela Cornacchia","orcid":"https://orcid.org/0000-0003-0897-8161","observed_orcids":["https://orcid.org/0000-0003-0897-8161"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Daniela Cornacchia","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026453959","display_name":"Sandeep Kumar Botla","orcid":"https://orcid.org/0000-0001-9937-0455","observed_orcids":["https://orcid.org/0000-0001-9937-0455"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Sandeep Botla","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093133634","display_name":"Linn Kullberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Linn Kullberg","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079179989","display_name":"Louise Stjernborg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Louise Stjernborg","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090807064","display_name":"Olivia G. Pembridge","orcid":"https://orcid.org/0000-0003-3121-9403","observed_orcids":["https://orcid.org/0000-0003-3121-9403"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Olivia Pembridge","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009503928","display_name":"Mahya Dezfouli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mahya Dezfouli","raw_affiliation_strings":["Mechanistic and Structural Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mechanistic and Structural Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074507662","display_name":"Naomi Lyons","orcid":"https://orcid.org/0000-0003-4255-2324","observed_orcids":["https://orcid.org/0000-0003-4255-2324"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Naomi Lyons","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109332285","display_name":"Joseph Collin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Joseph Collin","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022261295","display_name":"Leif Wigge","orcid":"https://orcid.org/0000-0003-4153-5354","observed_orcids":["https://orcid.org/0000-0003-4153-5354"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Leif Wigge","raw_affiliation_strings":["Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052116796","display_name":"Anna Forsl\u00f6w","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Anna Forsl\u00f6w","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065576131","display_name":"Mirko Messa","orcid":"https://orcid.org/0000-0001-7133-0152","observed_orcids":["https://orcid.org/0000-0001-7133-0152"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mirko Messa","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078080787","display_name":"Roxane Paulin","orcid":"https://orcid.org/0000-0003-1897-4703","observed_orcids":["https://orcid.org/0000-0003-1897-4703"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Roxane Paulin","raw_affiliation_strings":["Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024014884","display_name":"Ceri M. Wiggins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ceri Wiggins","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059019544","display_name":"Bilada Bilican","orcid":"https://orcid.org/0000-0002-3057-2654","observed_orcids":["https://orcid.org/0000-0002-3057-2654"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Bilada Bilican","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052758096","display_name":"Henric Olsson","orcid":"https://orcid.org/0000-0002-5101-8871","observed_orcids":["https://orcid.org/0000-0002-5101-8871"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Henric Olsson","raw_affiliation_strings":["Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057713208","display_name":"Davide Gianni","orcid":"https://orcid.org/0000-0002-6331-0677","observed_orcids":["https://orcid.org/0000-0002-6331-0677","https://orcid.org/0009-0005-6051-8201"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Davide Gianni","raw_affiliation_strings":["Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA5205","last_page":"PA5205"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10929","display_name":"Wnt/\u03b2-catenin signaling in development and cancer","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10929","display_name":"Wnt/\u03b2-catenin signaling in development and cancer","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/wnt-beta-catenin-signaling","display_name":"Wnt/\u03b2-catenin signaling","score":0.9990000128746033},{"id":"https://openalex.org/keywords/negative-regulator","display_name":"negative regulator","score":0.8939999938011169},{"id":"https://openalex.org/keywords/lung-epithelial-cells","display_name":"lung epithelial cells","score":0.9860000014305115},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.7200000286102295},{"id":"https://openalex.org/keywords/emphysema","display_name":"emphysema","score":0.9559999704360962},{"id":"https://openalex.org/keywords/pulmonary-fibrosis","display_name":"pulmonary fibrosis","score":0.7129999995231628},{"id":"https://openalex.org/keywords/myofibroblast-activation","display_name":"myofibroblast activation","score":0.9179999828338623},{"id":"https://openalex.org/keywords/alveolar-type-ii-cells","display_name":"alveolar type II cells","score":0.9480000138282776},{"id":"https://openalex.org/keywords/small-airway-epithelial-cells","display_name":"small airway epithelial cells","score":0.7990000247955322},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.746999979019165}],"concepts":[{"id":"https://openalex.org/C137620995","wikidata":"https://www.wikidata.org/wiki/Q155769","display_name":"Wnt signaling pathway","level":3,"score":0.9209812879562378},{"id":"https://openalex.org/C99732316","wikidata":"https://www.wikidata.org/wiki/Q18032812","display_name":"AXIN2","level":4,"score":0.7545861005783081},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6105163097381592},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.6018392443656921},{"id":"https://openalex.org/C182819311","wikidata":"https://www.wikidata.org/wiki/Q18028670","display_name":"LRP5","level":4,"score":0.5826886296272278},{"id":"https://openalex.org/C30145163","wikidata":"https://www.wikidata.org/wiki/Q384104","display_name":"Catenin","level":4,"score":0.43951216340065},{"id":"https://openalex.org/C163952510","wikidata":"https://www.wikidata.org/wiki/Q5058196","display_name":"Cell fate determination","level":4,"score":0.4239400625228882},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4122551679611206},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39927375316619873},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.16891264915466309},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13923799991607666},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1064351499080658}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2023.pa5205","doi":"https://doi.org/10.1183/13993003.congress-2023.pa5205","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2023.pa5205","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pathology and functional genomics","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1762842566","https://openalex.org/W1904133985","https://openalex.org/W2327478462","https://openalex.org/W4402328513","https://openalex.org/W2046759656","https://openalex.org/W1981037437","https://openalex.org/W2989994146","https://openalex.org/W7161577782","https://openalex.org/W1879934711","https://openalex.org/W2549557055"],"abstract_inverted_index":{"Wnt/\u03b2-catenin":[0,43],"signaling":[1,44,92],"plays":[2],"an":[3],"important":[4],"role":[5],"in":[6,18,55,66,107,174],"controlling":[7],"lung":[8,110],"epithelial":[9,28,69,177,206],"cell":[10,29,141,178,207,224],"homeostasis":[11],"and":[12,15,79,97,171,176,196,226],"fate":[13],"commitment":[14],"is":[16],"dysregulated":[17],"COPD":[19],"with":[20],"reduced":[21],"Wnt":[22,72,91,184],"activity.":[23],"As":[24,90],"it":[25],"controls":[26],"alveolar":[27,205,221],"self-renewal,":[30,225],"we":[31,99,227],"performed":[32,100],"a":[33,101,203,230],"whole":[34],"genome":[35],"CRISPR":[36],"screen":[37,103],"to":[38,130,210,219],"identify":[39,131],"negative":[40],"regulators":[41],"of":[42,135,159,186,188,214,234],"for":[45,71,81,87],"potential":[46,213],"regenerative":[47],"therapies":[48],"addressing":[49],"emphysema.":[50],"152":[51],"hits":[52,106,191],"were":[53,63],"identified":[54],"A549":[56],"cells":[57,70],"(p<0.1":[58],"vs.":[59],"neutral":[60],"control),":[61],"which":[62],"then":[64],"screened":[65],"small":[67,193],"airway":[68],"pathway":[73],"activation":[74,96,185],"by":[75],"\u03b2-catenin":[76],"nuclear":[77],"translocation":[78],"ViewRNA":[80],"AXIN2":[82],"expression,":[83,122,167],"yielding":[84],"34":[85],"candidates":[86],"further":[88],"progression.":[89],"may":[93],"drive":[94],"myofibroblast":[95],"fibrosis,":[98],"counter":[102],"on":[104],"these":[105],"normal":[108],"human":[109],"fibroblasts.":[111],"Our":[112],"control":[113],"gene":[114],"CSNK1A1":[115],"robustly":[116],"induced":[117,144,165],"\u03b1-smooth":[118],"muscle":[119],"actin":[120],"(\u03b1SMA)":[121],"indicating":[123],"that":[124],"the":[125,136,150,157,183,212,215,235],"assay":[126,209],"could":[127],"be":[128],"used":[129],"pro-fibrotic":[132],"targets.":[133,236],"Four":[134],"targets":[137,155,218],"investigated":[138],"either":[139],"caused":[140],"toxicity":[142],"or":[143],"\u226510%":[145],"increased":[146],"\u03b1SMA":[147,166],"expression":[148],"above":[149],"untreated":[151],"control.":[152],"Interestingly,":[153],"some":[154],"attenuated":[156],"effects":[158,170],"transforming":[160],"growth":[161],"factor":[162],"\u03b2":[163],"(TGF-\u03b2)":[164],"suggesting":[168],"anti-fibrotic":[169],"differential":[172],"roles":[173],"mesenchymal":[175],"lineages.":[179],"We":[180,199],"have":[181],"validated":[182],"one":[187],"our":[189],"top":[190,216],"using":[192],"molecule":[194],"inhibitor":[195],"RNA":[197],"interference.":[198],"are":[200,228],"currently":[201],"establishing":[202],"CRISPR-based":[204],"organoid":[208],"investigate":[211],"19":[217],"promote":[220],"type":[222],"II":[223],"performing":[229],"bioinformatics-based":[231],"hit":[232],"ranking":[233]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2023-10-28T00:00:00"}